Pentamidine Alleviates Inflammation and Lipopolysaccharide-Induced Sepsis by Inhibiting TLR4 Activation via Targeting MD2
Toll-like receptor 4 (TLR4) is a pattern-recognition receptor (PRR) that can recognize lipopolysaccharides (LPS) and initiate the immune response, to protect the body from infection. However, excessive activation of TLR4 induced by LPS leads to substantial release of pro-inflammatory factors, which...
Main Authors: | Siru Wu, Cong Lin, Tianshu Zhang, Bo Zhang, Yushan Jin, Hongshuang Wang, Hongyuan Li, Yibo Wang, Xiaohui Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.835081/full |
Similar Items
-
Cannabidivarin alleviates neuroinflammation by targeting TLR4 co-receptor MD2 and improves morphine-mediated analgesia
by: Xue Wang, et al.
Published: (2022-08-01) -
ACT001 Inhibits TLR4 Signaling by Targeting Co-Receptor MD2 and Attenuates Neuropathic Pain
by: Tianshu Zhang, et al.
Published: (2022-06-01) -
Nicotine and its metabolite cotinine target MD2 and inhibit TLR4 signaling
by: Hongyuan Li, et al.
Published: (2021-05-01) -
Pentamidine Inhibits Ovarian Cancer Cell Proliferation and Migration by Maintaining Stability of PTEN in vitro
by: Wu Y, et al.
Published: (2021-07-01) -
In vivo antileishmanial action of Ir-(COD)-pentamidine tetraphenylborate on Leishmania donovani and Leishmania major mouse models
by: Loiseau P.M., et al.
Published: (2000-06-01)